flow trial semaglutide kidney outcomes hazard ratio 0.76 Effects of with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic disease in the flow trial semaglutide kidney outcomes

Since you draw medicine from a vial, you get full control over your medication

Use an insulated travel case with cold packs (not frozen solid, just chilled) to keep the vial between 36 and 46 degrees Fahrenheit

All GLP-1RAs have been found to cross the bloodbrain barrier (BBB) and stimulate GLP-1 receptors in the brain, thus offering neuroprotection [17]

Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once-daily liraglutide in Japanese patients with type 2 diabetes: 52 weeks of treatment in a randomized phase III study

Direct Meds semaglutide is not a standalone solution

Critical rule: never place the medication directly against a frozen gel pack